Financhill
Sell
4

ALLO Quote, Financials, Valuation and Earnings

Last price:
$1.88
Seasonality move :
0.51%
Day range:
$1.78 - $1.93
52-week range:
$1.78 - $5.78
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3,959.29x
P/B ratio:
0.85x
Volume:
5M
Avg. volume:
2.7M
1-year change:
-32.73%
Market cap:
$392.1M
Revenue:
$95K
EPS (TTM):
-$1.56

Earnings Data

Next earnings date for ALLO
Mar 14
2025
Most recent earnings per share
-$0.32
Beat by $0.00
(Nov 7/2024)
Consensus Estimate
-$0.32
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ALLO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/14/2025 Q4 $12.1K -- -- -$0.33 --
11/07/2024 Q3 $10K -- -$0.32 -$0.32 $0.00
08/07/2024 Q2 $893.9K -- -$0.35 -$0.35 -$0.00
05/13/2024 Q1 $10.4K $22K -$0.38 -$0.41 $0.03
03/14/2024 Q4 $22.4K $21K -$0.51 -$0.44 -$0.07
11/02/2023 Q3 -- -- -$0.37 -$0.52 $0.15
08/02/2023 Q2 -- -- -$0.53 -$0.59 $0.06
05/03/2023 Q1 -- -- -$0.68 -$0.62 -$0.06
02/28/2023 Q4 -- -- -$0.66 -$0.69 $0.03
11/02/2022 Q3 -- -- -$0.58 -$0.65 $0.07
08/09/2022 Q2 -- -- -$0.52 -$0.61 $0.09
05/04/2022 Q1 -- -- -$0.56 -$0.58 $0.02
02/23/2022 Q4 -- -- -$0.54 -$0.59 $0.05
11/04/2021 Q3 -- -- -$0.57 -$0.56 -$0.01
08/04/2021 Q2 -- -- -$0.53 -$0.54 $0.01
05/05/2021 Q1 -- -- -$0.25 -$0.40 $0.15
02/25/2021 Q4 -- -- -$0.53 -$0.55 $0.02
11/04/2020 Q3 -- -- -$0.52 -$0.55 $0.03
08/05/2020 Q2 -- -- -$0.53 -$0.54 $0.01
05/06/2020 Q1 -- -- -$0.50 -$0.58 $0.08
02/27/2020 Q4 -- -- -$0.58 -$0.68 $0.10
11/05/2019 Q3 -- -- -$0.50 -$0.54 $0.04
08/07/2019 Q2 -- -- -$0.41 -$0.44 $0.03
05/07/2019 Q1 -- -- -$0.32 -$0.44 $0.12
03/08/2019 Q4 -- -- -$0.37 -$0.25 -$0.12
11/21/2018 Q3 -- -- -$0.43 -$0.39 -$0.04

Allogene Therapeutics Earnings Questions

  • How Much did Allogene Therapeutics Generate in Revenue Last Quarter?

    Allogene Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Allogene Therapeutics Beat Earnings Last Quarter?

    Allogene Therapeutics announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.32 per share.

  • Is Allogene Therapeutics Profitable?

    Allogene Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Allogene Therapeutics EPS Next Year?

    Allogene Therapeutics's earnings are forecast to decrease from -$2.09 per share to -$2.00 per share next year representing a decrease of -37.12%.

  • When is Allogene Therapeutics's Earnings Date?

    Allogene Therapeutics's next earnings date is March 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock